Since PURα seems to have oncogenic roles in ESCC cells, which is the opposite to the role seen in prostate cancer, the role of PURα, especially as a component of the NM, remains to be elucidated and further investigation needs to be performed. This evidence concerns the gene PURA and prostate cancer.